Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 82-86

  Mukherjee, Pranab K ^b   Leidich, Steven D ^b   Isham, Nancy ^b   Leitner, Ingrid ^a   Ryder, Neil S ^a   Ghannoum, Mahmoud A ^b  

^a Brunnerstra e 59   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BUTENAFINE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; NAFTIFINE; TERBINAFINE; TOLCICLATE; TOLNAFTATE;

ARTICLE; CROSS RESISTANCE; DERMATOPHYTE; DILUTION; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; TRICHOPHYTON;

EID: 12244304216     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.82-86.2003     Document Type: Article

References (27)

1. Borgers, M. 1980. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev. Infect. Dis. 2:520-534.
2. Bradley, M. C., S. Leidich, N. Isham, B. E. Elewski, and M. A. Ghannoum. 1999. Antifungal susceptibilities and genetic relatedness of serial Trychophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 42:105-110.
3. Brandt, M. E., M. A. Pfaller, R. A. Hajjeh, E. A. Graviss, J. Rees, E. D. Spitzer, R. W. Pinner, L. W. Mayer, et al. 1996. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. J. Infect. Dis. 174:812-820.
4. Chen, B. K., and S. F. Friedlander. 2001. Tinea capitis update: a continuing conflict with an old adversary. Curr. Opin. Pediatr. 13:331-335.
5. Coloe, S. V., and R. W. Baird. 1999. Dermatophyte infections in Melbourne: trends from 1961/64 to 1995/96. Pathology 31:395-397.
6. Crawford, F., P. Young, C. Godfrey, S. E. Bell-Syer, R. Hart, E. Brunt, and I. Russell. 2002. Oral treatments for toenail onychomycosis: a systematic review. Arch. Dermatol. 138:811-816.
7. Degreef, H. J., and P. R. DeDoncker. 1994. Current therapy of dermatophytosis. J. Am. Acad. Dermatol. 31:S25-S30.
8. Elewski, B. E. 1993. Mechanisms of action of systemic antifungal agents. J. Am. Acad. Dermatol. 28:S28-S34.
9. Fachin, A. L., C. M. Maffei, and N. M. Martinez-Rossi. 1996. In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trychophyton rubrum resistant to griseofulvin and tioconazole. Mycopathologia 135:141-143.
10. Favre, B., and N. S. Ryder. 1996. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob. Agents Chemother. 40:443-447.
11. Friedlander, S. F., R. Aly, B. Krafchik, J. Blumer, P. Honig, D. Stewart, A. W. Lucky, A. K. Gupta, D. E. Babel, B. Abrams, N. Gourmala, L. Wraith, and C. Paul. 2002. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics 109:602-607.
12. Georgopapadakou, N. H. 1998. Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbiol. 1:547-557.
13. Ghannoum, M. A., R. A. Hajjeh, R. Scher, N. Konnikov, A. K. Gupta, R. Summerbell, S. Sullivan, R. Daniel, P. Krusinski, P. Fleckman, P. Rich, R. Odom, R. Aly, D. Pariser, M. Zaiac, G. Rebell, J. Lesher, B. Gerlach, G. F. Ponce-De-Leon, A. Ghannoum, J. Warner, N. Isham, and B. Elewski. 2000. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J. Am. Acad. Dermatol. 43:641-648.
14. Ghannoum, M. A., and L. B. Rice. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:501-517.
15. Jackson, C. J., R. C. Barton, and E. G. Evans. 1999. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal DNA intergenic spacer regions. J. Clin. Microbiol. 37:931-936.
16. Jessup, C. J., N. S. Ryder, and M. A. Ghannoum. 2000. An evaluation of the in vitro activity of terbinafine. Med. Mycol. 38:155-159.
17. Jessup, C. J., J. Warner, N. Isham, I. Hasan, and M. A. Ghannoum. 2000. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates, J. Clin. Microbiol. 38:341-344.
18. Johnson, R. A. 2000. Dermatophyte infections in human immune deficiency virus (HIV) disease. J. Am. Acad. Dermatol. 43:S135-S142.
19. Kemna, M. E., and B. E. Elewski. 1996. A U.S. epidemiologic survey of superficial fungal diseases, J. Am. Acad. Dermatol. 35:539-542.
20. Leyden, J. 1998. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J. Am. Acad. Dermatol. 38:S42-S47,
21. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. Norris, H. A., B. E. Elewski, and M. A. Ghannoum. 1999. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J. Am. Acad. Dermatol. 40:S9-S13.
23. Pfaller, M. A., J. Rhine-Chalberg, S. W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32:59-64.
24. Ryder, N. S. 1992. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br. J. Dermatol. 126(Suppl. 39):2-7.
25. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
26. Weitzman, I., and R. C. Summerbell. 1995, The dermatophytes. Clin. Microbiol. Rev. 8:240-259.
27. Zhong, Z. R., R. Li, D. Li, and D. Wang. 1997. Typing of common dermatophytes by random amplification of polymorphic DNA. Jpn. J. Med. Mycol. 38:239-246.